Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

Radiology

Volumn 202, Issue 2, 1997, Pages 441-446

  Steinert, Hans C ^a   Hauser, Markus ^a   Allemann, Florin ^a   Engel, Hermann ^a   Berthold, Thomas ^a   Von Schulthess, Gustav K ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Computed tomography (CT), comparative studies; Emission CT (ECT), comparative studies; Lung neoplasms, metastases; Lung neoplasms, staging; Lymphatic system, neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0031028068     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.2.9015071     Document Type: Article

References (24)

1. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705-713.
2. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
3. Webb WR, Sarin M, Zerhouni EA, Heelan RT, Glazer GM, Gatsonis C. Interobserver variability in CT and MR staging of lung cancer. J Comput Assist Tomogr 1993; 17: 841-846.
4. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60:2682-2689.
5. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990; 311:1927-1933.
6. Gupta NC, Frank AR, Dewan N, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184: 441-444.
7. Patz EF, Lowe VJ, Hoffmann JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188:487-490.
8. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mcdiastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191:371-377.
9. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793.
10. Lowe VJ, DeLong DM, Hoffmann JM, Coleman RE. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med 1995; 36:883-887.
11. Bury T, Dowlati A, Paulus P, Hustinx R, Radermaker M, Rigo P. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography. Eur J Nucl Med 1996; 23:204-206.
12. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med 1996; 23:741-747.
13. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238.
14. Engel H, Steinert H, Buck A, et al. Wholebody PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996; 37:441-446.
15. Glazer GM, Orringer MB, Gross BH, Quint LE. The mediastinum in non-small cell lung cancer: CT-surgical correlation. AJR 1984; 142:1101-1105.
16. Tisi GM, Friedman PH, Peters RM, et al. American Thoracic Society: clinical staging of primary lung cancer. Am Rev Respir Dis 1983; 127:659-664.
17. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995; 36:1836-1839.
18. Fischmann AJ. Positron emission tomography in the clinical evaluation of metastatic cancer. J Clin Oncol 1996; 14:691-696.
19. Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34:355-359.
20. Hamberg LM, Hunter GJ, Alpert NM, et al. The dose uptake ratio: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-1312.
21. Lowe VJ, Hoffmann JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776.
22. Cherry SR, Dahlbom M, Hoffman EJ. 3D PET using a conventional multislice tomograph without septa. J Comput Assist Tomogr 1991; 15:655-668.
23. Bailey DL. 3D acquisition and reconstruction in positron emission tomography. Ann Nucl Med 1992; 6:123-130.
24. Meikle SR, Bailey DL, Hooper PK, et al. Simultaneous emission and transmission measurements for attenuation correction in whole-body PET. J Nucl Med 1995; 36:1680-1688.